Herein, IFN-α treatment dramatically suppressed the viability, migratory ability, and invasive ability of glioma cells, whereas CYBRD1 overexpression attenuated IFN-α-induced inhibition upon the aggressiveness of glioma cells. Here, CYBRD1 is linked to central nervous system cancer.